Disparities in liver-related care among transgender adults with steatotic liver disease: a retrospective cohort study
Journal of the Endocrine Society · 03.06.2026 · 10 (7)
DOI: 10.1210/jendso/bvag129 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the Endocrine Society, online erschienen am 13.06.2026. Verfasst von Maria Ortega Abad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Transgender (TGD) adults experience healthcare disparities across multiple domains, yet care for steatotic liver disease (SLD) remains uninvestigated.
Aims
Evaluate whether TGD adults with SLD receive equitable liver-related care compared with cisgender (CGD) adults.
Methods
Retrospective cohort study conducted at a tertiary medical center (2015-2025). Adults with SLD were identified by a 2-step process (ICD-10 codes, manual chart review). Patients with other causes of liver disease and missing data were excluded. TGD status was defined by ICD-10 codes for gender dysphoria, documented gender incongruence or use of gender affirming hormone therapy. Controls and cases were selected from the same cohort with a 2:1 sampling ratio. Primary outcomes, gastroenterology consultation, hepatology assessment (FIB-4, elastography, or biopsy), and advanced workup, were analyzed using logistic regression adjusting for age and cardiometabolic covariates. An age restricted (30-60) sensitivity analysis was performed. Secondary outcomes included viral hepatitis screening/vaccination, SLD-directed therapies, and 5-year BMI trajectories.
Results
Among 254 adults (85 TGD, 169 CGD), TGD individuals were younger (36.0 vs 57.0 years, P < .001) with higher MASLD prevalence (91.8% vs 77.5%, P = .05). TGD status was associated with lower odds of gastroenterology consultation (aOR 0.41; 95% CI .18–.93), any hepatology assessment (aOR 0.35; 95% CI .18–.70), advanced hepatology workup (aOR 0.34; 95% CI .17–.69), with robust findings in sensitivity analysis. GLP-1 agonist prescriptions were lower (9.4% vs 19.5%, P = .03), and BMI increased vs controls (P < .001).
Conclusion
TGD adults with SLD experience substantial disparities in care, requiring integrated, inclusive pathways to advance health equity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrinology and Metabolism Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
- Department of Internal Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
- Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA 94305, USA.
ORCID-Profile: Maria Ortega Abad
Zitieren
APA
Ortega Abad, M., Sierra, L., Duong, N., & Correa, R. (2026). Disparities in liver-related care among transgender adults with steatotic liver disease: a retrospective cohort study. Journal of the Endocrine Society, 10(7). https://doi.org/10.1210/jendso/bvag129
Vancouver
Ortega Abad M, Sierra L, Duong N, Correa R. Disparities in liver-related care among transgender adults with steatotic liver disease: a retrospective cohort study. Journal of the Endocrine Society. 2026;10(7). doi:10.1210/jendso/bvag129
BibTeX
@article{OrtegaAbad2026,
author = {Ortega Abad, Maria and Sierra, Leandro and Duong, Nikki and Correa, Ricardo},
title = {Disparities in liver-related care among transgender adults with steatotic liver disease: a retrospective cohort study},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {7},
doi = {10.1210/jendso/bvag129}
}
EUVIMED